{"groups":[{"description":"Open-label doxycycline 100 mg twice daily by mouth will be administered to subjects for 12 months.","id":"FG000","title":"Doxycycline 100 mg po Bid x 12 Months"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"25"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"14"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"11"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"Patients referred to an amyloidosis center and no longer requiring active treatment to control progressive disease were recruited to the study."}